| Entry |
|
|---|
| Name |
Caracemide (USAN) |
|---|
| Formula |
C6H11N3O4
|
|---|
| Exact mass |
189.0750
|
|---|
| Mol weight |
189.17
|
|---|
| Structure |
|
|---|
| Class |
Neuropsychiatric agent
DG01595 Cholinesterase inhibitor
DG01593 Acetylcholinesterase inhibitor
|
|---|
| Efficacy |
Antineoplastic, Antimetabolite |
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01595 Cholinesterase inhibitor
DG01593 Acetylcholinesterase inhibitor
D03378 Caracemide
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Ribonucleoside-diphosphate reductase
RRM1
D03378 Caracemide (USAN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 13
1 C1a C 7.2100 -12.6000
2 N1b N 8.4224 -11.9000
3 C7a C 9.6349 -12.6000
4 O7a O 10.8473 -11.9000
5 N1c N 12.0597 -12.6000
6 O6a O 9.6349 -13.9998
7 C5a C 13.2573 -11.9085
8 N1b N 14.4456 -12.5945
9 O5a O 13.2574 -10.5003
10 C1a C 15.6364 -11.9069
11 C5a C 12.0598 -13.9999
12 C1a C 13.2574 -14.6914
13 O5a O 10.8325 -14.7086
BOND 12
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 3 6 2
6 5 7 1
7 7 8 1
8 7 9 2
9 8 10 1
10 5 11 1
11 11 12 1
12 11 13 2
|
|---|
